Find a TenderAwarded

Published 15 Dec 2023, 13:55 GMT

Official UK procurement notice

Generic Drugs - Injections/Infusions

Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)·Consortium: 2 public authorities

GoodsOpen procedure

Sectors: Medical Devices & Pharma (33) Delivery: UKWales (UKL)

Published estimate£15,382,134≈ £7.7m / year

Submissions closed 18 Jan 2024awarded 30 Jun 2024

Awarded to Aguettant Ltd +9 more10 awards

Contract term 2 yrsends 30 Jun 2026 · extension options published · starts 1 Jul 2024

What is being bought

Published requirement description

Generic Drugs - Injections/Infusions

CPV: Pharmaceutical products

The lotProcurement structure

single lot · value published

Lot #1AwardedRenewal 2 yrsPublished value£15,382,134

Contract period: 1 Jul 2024 – 30 Jun 2026 (2 yrs)

Delivery: UK, Wales

Extensions: There is a possibility to extend up to a further 24 monthsVariant bids: allowed

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price: 170Social value: 15

Published sub-criteria (5)

Financial (overall cost of contract): 85
Price: 65
Price stability: 16
Minimum Order Value: 4
Social Value/Community Benefits: 15

Published award criteria (6)

Product Quality/Acceptability: Pass/Fail
Financial (overall cost of contract): 85
Social Value/Community Benefits: 15
Price: 65
Price stability: 16
Minimum Order Value: 4

Conditions of participation1

Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner:
1. ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
1. SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
(i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗
(ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page
(iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button
(iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at help@bravosolution.co.uk

What this means for your bid

Price carries 170 of 185 points: a 10% discount moves about 17 points. This one is won on the number: sharpen the price before polishing the prose.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Yes
First published: 15 Dec 2023, 13:55 GMT
Last source update: 31 Jul 2024, 13:43 BST
Award evaluation window: 18 Jan 2024 – …
Authority reference: PAD-OJEU-54914
FTS notice number: 2024/S 000-023952
Classification (CPV): Pharmaceutical products
Delivery area: UKWales (UKL)
Official registry OCID: ocds-h6vhtk-042618 Find a Tender

Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements.

How it was run

Official notice

Run through: Jaggaer · Who buys & how to bid on Sell2Wales

Supplier login requiredLanguage: EN

Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail

Tender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗

Submission deadline: 18 Jan 2024, 10:00 GMT
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Participation fee: document
Bids opened: 18 Jan 2024, 10:01 GMT

Detailed submission instructions & authority contactsFrom official release

www.etenderwales.bravosolution.co.uk/nhs/ ↗

Timeline

18 Jan 2024 → 31 Jul 2024 · 4 dates

Submission deadline
18 Jan 2024, 10:00 GMT
Bids opened
18 Jan 2024, 10:01 GMT
Contract starts
1 Jul 2024, 00:00 BST
Notice published
31 Jul 2024, 13:43 BST

Notice history

2 events · 2 releases on Find a Tender · since 31 Jul 2024

Status changed to complete
31 Jul 2024, 13:43 BST
Buyer details updated
31 Jul 2024, 13:43 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 41

Awarded value £31,493,56020 contracts exc. VAT

Bids received 56

Contracts signed 20latest 30 Jun 2024

Awarded to	Value	Date	Status
Aguettant Ltd	£7,470,304 †	—	Awarded
Desitin Pharma Ltd	£106,892 †	—	Awarded
Dr Reddy's Laboratories (UK) Ltd	£257,140 †	—	Awarded
DRUGSRUS LTD	£1,272,848 †	—	Awarded
Esteve Pharmaceuticals Ltd	£90,548 †	—	Awarded
Ferring Pharmaceuticals Limited	£321,100 †	—	Awarded
Flexipharm Austrading Limited	£107,520 †	—	Awarded
Flynn Pharma Ltd	£245,496 †	—	Awarded
Focus Pharmaceuticals Ltd	£60,388 †	—	Awarded
Fresenius Kabi Limited	£3,470,496 †	—	Awarded

31 further award records carry no date or value.

Contracts

Generic Drugs - Injections/Infusions · Aguettant Ltd
Signed
30 Jun 2024
Value
£7,470,304
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Desitin Pharma Ltd
Signed
30 Jun 2024
Value
£106,892
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Dr Reddy's Laboratories (UK) Ltd
Signed
30 Jun 2024
Value
£257,140
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · DRUGSRUS LTD
Signed
30 Jun 2024
Value
£1,272,848
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Esteve Pharmaceuticals Ltd
Signed
30 Jun 2024
Value
£90,548
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Ferring Pharmaceuticals Limited
Signed
30 Jun 2024
Value
£321,100
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Flexipharm Austrading Limited
Signed
30 Jun 2024
Value
£107,520
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Flynn Pharma Ltd
Signed
30 Jun 2024
Value
£245,496
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Focus Pharmaceuticals Ltd
Signed
30 Jun 2024
Value
£60,388
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions · Fresenius Kabi Limited
Signed
30 Jun 2024
Value
£3,470,496
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£1,785,940
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£373,968
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£36,160
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£1,686,500
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£1,491,432
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£299,232
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£6,474,592
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£5,822,168
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£26,212
Period
… – 30 Jun 2026
Status
active
Generic Drugs - Injections/Infusions
Signed
30 Jun 2024
Value
£94,624
Period
… – 30 Jun 2026
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
56bids	—	—	—

Contracting authority & participating public bodies

2 public bodies on the notice

Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)

Contracting authorityNHS & healthcareBody governed by public lawHealth IP5 Imperial Park, Celtic Way, Newport, UK, NP10 8BEContact name, email, phone

Consortium members and other public bodies

NHS Shared Services PartnershipContracting authorityCentral purchasing bodyBody governed by public lawHealth Newport, UKContact name, email, phone Published organisation website ↗

Bidders & participating suppliers

41 commercial parties on the notice

AOP Orphan PharmaceuticalsAwarded supplier Austria, UK
Aguettant LtdAwarded supplier Bristol, UK
Aspen Pharmacare UKAwarded supplier London, UK
B Braun MedicalAwarded supplier Sheffield, UK
Baxter HealthcareAwarded supplier Berkshire, UK
Beaumont PharmaAwarded supplier Burnley, UK
Bowmed IbisqusAwarded supplier Wrexham, UK
CST PharmaAwarded supplier Walsall, UK
Chiesi LimitedAwarded supplier Manchester, UK
Desitin PharmaAwarded supplier Milton Keynes, UK

Show 31 more suppliers

Dr Reddy's LaboratoriesAwarded supplier Cambridge, UK
DrugsrusAwarded supplier Middlesex, UK
Esteve PharmaceuticalsAwarded supplier Berkshire, UK
Ferring PharmaceuticalsAwarded supplier West Drayton, UK
Flexipharm AustradingAwarded supplier Bucks, UK
Flynn PharmaAwarded supplier Herts, UK
Focus PharmaceuticalsAwarded supplier London, UK
Fresenius KabiAwarded supplier Cheshire, UK
Hameln PharmaAwarded supplier Gloucester, UK
Hikma PharmaceuticalsAwarded supplier London, UK
JanssenAwarded supplier Buckinghamshire, UK
Kent PharmaceuticalsAwarded supplier Kent, UK
LundbeckAwarded supplier Milton Keynes, UK
MSN LaboratoriesAwarded supplier Hertfordshire, UK
MartindaleAwarded supplier Essex, UK
Mercury PharmaceuticalsAwarded supplier London, UK
Neon HealthcareAwarded supplier Hertfordshire, UK
PM PharmaAwarded supplier Norfolk, UK
Panpharma UKAwarded supplier Southport, UK
Pfizer LimitedAwarded supplier Surrey, UK
Piramal Critical CareAwarded supplier West Drayton, UK
RPH PharmaceuticalsAwarded supplier Cheadle, UK
SandozAwarded supplier Surrey, UK
Seacross PharmaceuticalsAwarded supplier Bedfordshire, UK
Sun Pharma UKAwarded supplier Uxbridge, UK
Tetris PharmaAwarded supplier Buckinghamshire, UK
Teva UKAwarded supplier West Yorkshire, UK
Thornton & RossAwarded supplier Huddersfield, UK
Torbay PharmaceuticalsAwarded supplier Devon, UK
Viatris UK HealthcareAwarded supplier Herts, UK
WockhardtAwarded supplier Wrexham, UK

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

Economic and financial selection criteriatenderEconomic and financial selection criteria
Technical selection criteriatenderTechnical selection criteria